儿童神经母细胞瘤的免疫治疗进展:通过生物标志物指导的联合方案克服耐药 Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations. PubMed 2026/01/31 发表Biomed Pharmacother 人群:儿童靶点:GD2技术:CAR-T技术:溶瘤病毒技术:双特异性抗体神经母细胞瘤淋巴瘤